Tessera Health

Finds the right patients for clinical trials in days instead of months, using hospital records with privacy built in.

Tessera Health LtdSingapore, Central Singapore, Singapore
Reviewed by our teamSeed stageData Analysis & AnalyticsLab ServicesMarket Research

About

Eight out of ten clinical trials miss their recruitment deadline, which delays new medicines and costs sponsors millions. Tessera reads de-identified hospital records to find patients who match a trial's criteria and alerts their doctors, who decide whether to suggest the trial.

Patient data never leaves the hospital: our software runs inside each hospital's own systems and only shares counts and alerts. We started in Singapore and are expanding to Malaysia, Thailand and Australia.

The problem

80% of clinical trials miss recruitment targets, delaying new treatments.

Our solution

Software inside hospitals that matches patients to trials and alerts their doctors.

Who it is for

Pharmaceutical companies and research organisations running trials in Asia-Pacific. Patient recruitment services are a USD 4bn market.

Traction so far

  • 6 hospitals connected
  • Recruitment time cut from 9 months to 6 weeks in two oncology trials
  • Contracts with 3 global pharmaceutical companies
  • Approved by hospital ethics boards in Singapore and Malaysia

Business model

Fee per trial plus a fee per enrolled patient, paid by trial sponsors. From USD 40,000 per trial.

Why we will win

Recruitment agencies, TriNetX, Deep 6 AI. Our software runs inside the hospital, which wins approvals faster.

Growth plan

Add 10 hospitals a year across ASEAN and Australia.

The raise

Raising USD 3m seed. Hospital integrations (50%), regulatory team (25%), sales in Australia (25%).

Photos

Highlights

6 hospitals connected

Recruitment time cut from 9 months to 6 weeks in two oncology trials

Contracts with 3 global pharmaceutical companies

Approved by hospital ethics boards in Singapore and Malaysia

The Idea

Problem

80% of clinical trials miss recruitment targets, delaying new treatments.

Solution

Software inside hospitals that matches patients to trials and alerts their doctors.

Target Market

Pharmaceutical companies and research organisations running trials in Asia-Pacific.

Market Size

Patient recruitment services are a USD 4bn market.

Growth Strategy

Add 10 hospitals a year across ASEAN and Australia.

Revenue Model

Fee per trial plus a fee per enrolled patient, paid by trial sponsors.

Pricing Strategy

From USD 40,000 per trial.

Competitors

Recruitment agencies, TriNetX, Deep 6 AI.

Competitive Advantage

Our software runs inside the hospital, which wins approvals faster.

Funding Requirement

Raising USD 3m seed.

Use of Funds

Hospital integrations (50%), regulatory team (25%), sales in Australia (25%).

The Team

Tessera Health is led by Mei Lin Tan (Co-founder & CEO), Yasmin Bianchi (Co-founder & CTO), Adam Romero (Chief Operating Officer). The team combines deep industry experience with a track record of shipping products customers love.

Mei Lin Tan

Co-founder & CEO

Mei Lin founded Tessera Health and leads strategy, fundraising and the team. Previously spent six years at a Big Four consultancy.

YB

Yasmin Bianchi

Co-founder & CTO

Yasmin leads the technology and engineering team. Previously built payment systems at a European fintech.

LinkedIn profile
AR

Adam Romero

Chief Operating Officer

Adam runs day-to-day operations and customer delivery. Former product manager at a global e-commerce company.

IN

Iris Nair

Head of Product

Iris owns the product roadmap and user research. Holds a PhD in engineering and has two patents.

LinkedIn profile

Documents & Decks

Discussions

No questions yet

Be the first to ask Tessera Health a question. Answers are public.

$3,000,000

for 10% equity · min $100,000

Message founders